8T5P
SARS-CoV-2 ORF3a peptide in complex with TRAF3 TRAF domain
8T5P の概要
エントリーDOI | 10.2210/pdb8t5p/pdb |
分子名称 | TNF receptor-associated factor 3, ORF3a protein (3 entities in total) |
機能のキーワード | signaling protein-viral protein complex, signaling protein/viral protein |
由来する生物種 | Homo sapiens (human) 詳細 |
タンパク質・核酸の鎖数 | 9 |
化学式量合計 | 132542.53 |
構造登録者 | |
主引用文献 | Busscher, B.M.,Befekadu, H.B.,Liu, Z.,Xiao, T.S. SARS-CoV-2 ORF3a-Mediated NF-kappa B Activation Is Not Dependent on TRAF-Binding Sequence. Viruses, 15:-, 2023 Cited by PubMed Abstract: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has caused a global pandemic of Coronavirus Disease 2019 (COVID-19). Excessive inflammation is a hallmark of severe COVID-19, and several proteins encoded in the SARS-CoV-2 genome are capable of stimulating inflammatory pathways. Among these, the accessory protein open reading frame 3a (ORF3a) has been implicated in COVID-19 pathology. Here we investigated the roles of ORF3a in binding to TNF receptor-associated factor (TRAF) proteins and inducing nuclear factor kappa B (NF-κB) activation. X-ray crystallography and a fluorescence polarization assay revealed low-affinity binding between an ORF3a N-terminal peptide and TRAFs, and a dual-luciferase assay demonstrated NF-κB activation by ORF3a. Nonetheless, mutation of the N-terminal TRAF-binding sequence PIQAS in ORF3a did not significantly diminish NF-κB activation in our assay. Our results thus suggest that the SARS-CoV-2 protein may activate NF-κB through alternative mechanisms. PubMed: 38005906DOI: 10.3390/v15112229 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.5 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード